International Value Advisers LLC Raises Stake in CVS Health Corp (CVS)

International Value Advisers LLC increased its position in CVS Health Corp (NYSE:CVS) by 97.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,282,701 shares of the pharmacy operator’s stock after buying an additional 1,129,387 shares during the period. CVS Health Corp comprises approximately 6.1% of International Value Advisers LLC’s portfolio, making the stock its 5th largest position. International Value Advisers LLC’s holdings in CVS Health Corp were worth $180,128,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in CVS. East Coast Asset Management LLC. increased its stake in CVS Health Corp by 0.3% in the third quarter. East Coast Asset Management LLC. now owns 2,439 shares of the pharmacy operator’s stock worth $217,000 after buying an additional 8 shares in the last quarter. Signature Financial Management Inc. increased its stake in CVS Health Corp by 0.3% in the third quarter. Signature Financial Management Inc. now owns 3,400 shares of the pharmacy operator’s stock worth $303,000 after buying an additional 9 shares in the last quarter. Affinity Investment Advisors LLC increased its stake in CVS Health Corp by 0.7% in the third quarter. Affinity Investment Advisors LLC now owns 2,775 shares of the pharmacy operator’s stock worth $247,000 after buying an additional 20 shares in the last quarter. Independent Investors Inc. increased its stake in CVS Health Corp by 0.3% in the third quarter. Independent Investors Inc. now owns 6,020 shares of the pharmacy operator’s stock worth $535,000 after buying an additional 20 shares in the last quarter. Finally, Burke & Herbert Bank & Trust Co. increased its stake in CVS Health Corp by 0.3% in the third quarter. Burke & Herbert Bank & Trust Co. now owns 6,250 shares of the pharmacy operator’s stock worth $556,000 after buying an additional 21 shares in the last quarter. 81.29% of the stock is currently owned by hedge funds and other institutional investors.

Institutional Ownership by Quarter for CVS Health Corp (NYSE:CVS)

CVS Health Corp (NYSE:CVS) opened at 78.88 on Monday. CVS Health Corp has a 52-week low of $69.30 and a 52-week high of $106.67. The firm has a market cap of $83.69 billion, a price-to-earnings ratio of 16.07 and a beta of 0.85. The stock has a 50 day moving average of $79.27 and a 200-day moving average of $82.31.

CVS Health Corp (NYSE:CVS) last posted its quarterly earnings data on Thursday, February 9th. The pharmacy operator reported $1.71 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.67 by $0.04. CVS Health Corp had a net margin of 3.00% and a return on equity of 17.55%. The company earned $46 billion during the quarter, compared to analyst estimates of $46.56 billion. During the same quarter last year, the firm posted $1.53 EPS. The business’s revenue for the quarter was up 11.7% on a year-over-year basis. On average, analysts expect that CVS Health Corp will post $5.86 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, May 1st. Stockholders of record on Friday, April 21st will be given a dividend of $0.50 per share. The ex-dividend date is Wednesday, April 19th. This represents a $2.00 annualized dividend and a dividend yield of 2.54%. CVS Health Corp’s dividend payout ratio (DPR) is 40.65%.

Your IP Address:

A number of analysts recently commented on the stock. Oppenheimer Holdings Inc. set a $88.00 price objective on shares of CVS Health Corp and gave the stock a “buy” rating in a report on Sunday, December 18th. Leerink Swann set a $90.00 target price on shares of CVS Health Corp and gave the stock a “buy” rating in a research report on Saturday, February 11th. Vetr cut shares of CVS Health Corp from a “buy” rating to a “hold” rating and set a $82.45 target price for the company. in a research report on Thursday, February 16th. Jefferies Group LLC assumed coverage on shares of CVS Health Corp in a research report on Monday, December 12th. They set a “hold” rating and a $82.00 target price for the company. Finally, Deutsche Bank AG restated a “hold” rating and set a $88.00 target price on shares of CVS Health Corp in a research report on Wednesday, February 8th. Eight equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. CVS Health Corp presently has an average rating of “Buy” and an average price target of $95.99.

In other news, EVP Jonathan C. Roberts sold 61,196 shares of the firm’s stock in a transaction dated Thursday, February 16th. The shares were sold at an average price of $80.00, for a total transaction of $4,895,680.00. Following the completion of the transaction, the executive vice president now owns 89,955 shares in the company, valued at approximately $7,196,400. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, EVP Andrew Sussman sold 14,104 shares of the firm’s stock in a transaction dated Monday, March 13th. The shares were sold at an average price of $80.40, for a total transaction of $1,133,961.60. Following the transaction, the executive vice president now owns 22,801 shares of the company’s stock, valued at approximately $1,833,200.40. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 170,918 shares of company stock valued at $13,744,102. Insiders own 0.58% of the company’s stock.

About CVS Health Corp

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

5 Day Chart for NYSE:CVS

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/international-value-advisers-llc-raises-stake-in-cvs-health-corp-cvs/1708644.html

Receive News & Ratings for CVS Health Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corp and related companies with MarketBeat.com's FREE daily email newsletter.

 

Leave a Reply

Your email address will not be published. Required fields are marked *